Mirae Asset Global Etfs Holdings Ltd. Eye Point Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 33,962 shares of EYPT stock, worth $463,920. This represents 0.0% of its overall portfolio holdings.
Number of Shares
33,962
Previous 38,660
12.15%
Holding current value
$463,920
Previous $209,000
52.63%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding EYPT
# of Institutions
159Shares Held
67.1MCall Options Held
214KPut Options Held
994K-
Cormorant Asset Management, LP Boston, MA8.33MShares$114 Million7.9% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.8MShares$92.9 Million2.2% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA6.8MShares$92.9 Million0.11% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.6MShares$62.8 Million0.09% of portfolio
-
Franklin Resources Inc San Mateo, CA4.3MShares$58.8 Million0.01% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $465M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...